ASML's Bullish Re-Rating Collides With a Shanghai Shadow
Published on 08/11/2026 at 23:51 | Redaktion boerse-global.de
The tug-of-war over ASML Holding's stock has rarely been this visible. On one side sits a wave of Wall Street conviction and record-breaking demand from the world's biggest chipmakers. On the other, a state-backed Chinese effort to build competing lithography tools — technology that has long been one of ASML's most profitable franchises.
For now, the bulls are winning. The Dutch lithography giant's shares climbed 2.95 percent on Tuesday to €1,551.40, extending a rally that began after two influential brokerages upgraded their outlook for the stock. That followed an even sharper 4.22 percent jump on the previous session, when the shares touched €1,570.60.
Two Analyst Nods, One Clear Message
The catalyst for the latest leg higher came Monday, when Goldman Sachs added ASML to its European Conviction List for August 2026 — a curated roster of stocks the bank believes carry exceptional upside. Bernstein went a step further, naming the company its top idea for the third quarter of 2026 while reaffirming an "Outperform" rating and a €2,500 price target.
The twin endorsements triggered a visible wave of institutional buying. Even with the recent gains, ASML still trades roughly 38 percent below Bernstein's target, leaving ample room for further appreciation if the analysts are right. A quieter adjustment came from Erste Group Bank, which in early August lifted its 2026 earnings-per-share estimate for ASML from $44.50 to $45.23 — a pure forecast revision with no change to its rating.
Buybacks Tell Their Own Story
The company itself has been signaling confidence through its share repurchase program. During the first week of August, ASML bought back roughly €78 million worth of its own stock each day. On August 7, it acquired 51,871 shares at a weighted average price of €1,506.07; the day before, it purchased 52,907 shares at €1,476.63. Those buyback prices sit noticeably below the current trading level — a reminder of how swiftly the stock has recovered.
Should investors sell immediately? Or is it worth buying ASML Holding?
The China Question Refuses to Fade
That recovery follows a nervous stretch in late July, when a Bloomberg report revealed that a Chinese state-backed company had begun coordinating mass production of immersion DUV lithography systems — the very technology ASML sells into China. Reuters Breakingviews later characterized the market's initial reaction as overblown, and the recent price action appears to support that assessment. ASML still trades about 11.25 percent below its 52-week high of €1,748.00, but it has clawed back much of the China-driven losses.
The competitive threat, however, hasn't disappeared. Shanghai Aishengna Electronic Technology Group is reportedly coordinating limited production of immersion DUV systems, though these machines remain in early testing and lag ASML's scanners significantly on performance, reliability, and build quality. Their commercial viability is unproven, and actual deployment remains unconfirmed. Still, Beijing has reportedly instructed domestic chipmakers to prioritize homegrown equipment for new capacity, which could erode what has historically been a highly profitable revenue stream for ASML.
Washington is adding another layer of pressure. The US Congress is debating the MATCH Act, legislation that could ban both the export and the servicing of immersion DUV systems for Chinese customers. Given China's substantial share of ASML's system sales, a rapid decline in Chinese orders would hit the financials hard.
A Fundamental Floor
The bull case rests on an unmistakable demand surge. TSMC has posted its third consecutive monthly revenue record and raised its capital expenditure plans. Intel is simultaneously advancing a larger capital raise to expand its manufacturing capacity. Micron has also boosted its investment outlook. All three are clamoring for ASML's EUV and advanced DUV systems — the most expensive and critical machines in their production lines.
ASML's management has responded by lifting its full-year 2026 revenue forecast from €36–40 billion to €43–45 billion. The second quarter delivered net revenue of €9.33 billion and net profit of €2.92 billion. The company is also expanding manufacturing capacity for low-NA EUV and DUV immersion systems to meet the wave of orders.
The stock's technical picture reflects the balance of forces. It has gained nearly 153 percent over the past twelve months and trades roughly 28 percent above its 200-day moving average — a sign of an intact long-term uptrend. The 14-day relative strength index sits at 56.6, suggesting the market has digested the geopolitical noise without tipping into euphoria or panic.
ASML Holding at a turning point? This analysis reveals what investors need to know now.
What Could Break the Rally
The bearish scenario hinges on a structural decline in China — a market that has been a cornerstone of ASML's profitability. Beyond the Shanghai effort, Canon continues to market its nanoimprint lithography as a cheaper, more energy-efficient alternative to traditional EUV, though throughput remains a bottleneck; ASML's high-speed EUV scanners process several hundred wafers per hour.
Should Chinese DUV orders demonstrably decline in coming quarters, or should the US Senate pass the MATCH Act, the revenue outlook could darken faster than current estimates suggest. A pullback toward the 50-day moving average of roughly €1,550 — just over one percent below Tuesday's close — would signal that the market is starting to price in those risks more seriously.
Two developments bear watching: the legislative path of the MATCH Act through the US Senate, and the first concrete results from Shanghai Aishengna's testing phase. Both will help determine whether ASML's Chinese franchise remains as durable as its order book suggests.
Ad
ASML Holding Stock: New Analysis - 11 August
Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
